MEMPHIS, Tenn.--(BUSINESS WIRE)--Aug. 30, 2018--
GTx, Inc. (Nasdaq: GTXI) today announced that Robert J. Wills, PhD,
Executive Chairman, and other senior executive management team members
will present a company overview at the Baird 2018 Global Healthcare
Conference on Thursday, September 6, 2018 at 9:05 am ET in New York.
A simultaneous webcast of the presentation can be accessed by visiting
the investor relations section of the GTx website at http://www.gtxinc.com.
A replay of the presentation will also be available and archived on the
site for 30 days.
GTx, Inc., headquartered in Memphis, Tenn., is a biopharmaceutical
company dedicated to the discovery, development and commercialization of
medicines to treat serious and/or significant unmet medical conditions,
including stress urinary incontinence and prostate cancer.
View source version on businesswire.com: https://www.businesswire.com/news/home/20180830005108/en/
Source: GTx, Inc.
Minarovich or Sam Martin
Denise Powell, 510-703-9491